ID   K7M2-WT
AC   CVCL_V455
SY   K7M2 wt; K7M2
DR   BTO; BTO:0006407
DR   ATCC; CRL-2836
DR   CCRID; 1101MOU-PUMC000820
DR   CCRID; 3101MOUTCM38
DR   CLS; 305188
DR   Wikidata; Q54899432
RX   PubMed=11315100;
RX   PubMed=17671136;
RX   PubMed=26320182;
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W624 ! K7 [Mouse osteosarcoma]
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 17
//
RX   PubMed=11315100; DOI=10.1023/A:1006767007547;
RA   Khanna C., Prehn J., Yeung C., Caylor J., Tsokos M.G., Helman L.J.;
RT   "An orthotopic model of murine osteosarcoma with clonally related
RT   variants differing in pulmonary metastatic potential.";
RL   Clin. Exp. Metastasis 18:261-271(2000).
//
RX   PubMed=17671136; DOI=10.1158/1078-0432.CCR-07-0313;
RA   Gordon N., Koshkina N.V., Jia S.-F., Khanna C., Mendoza A., Worth L.L.,
RA   Kleinerman E.S.;
RT   "Corruption of the Fas pathway delays the pulmonary clearance of
RT   murine osteosarcoma cells, enhances their metastatic potential, and
RT   reduces the effect of aerosol gemcitabine.";
RL   Clin. Cancer Res. 13:4503-4510(2007).
//
RX   PubMed=26320182; DOI=10.18632/oncotarget.5177;
RA   Ren L., Mendoza A., Zhu J., Briggs J.W., Halsey C., Hong E.S.,
RA   Burkett S.S., Morrow J.J., Lizardo M.M., Osborne T., Li S.Q.,
RA   Luu H.H., Meltzer P.S., Khanna C.;
RT   "Characterization of the metastatic phenotype of a panel of
RT   established osteosarcoma cells.";
RL   Oncotarget 6:29469-29481(2015).
//